Casma Therapeutics fetches $50m Series B

Cambridge, Massachusetts-based Casma Therapeutics Inc., a biotechnology company, has secured $50 million in Series B financing.

Cambridge, Massachusetts-based Casma Therapeutics Inc., a biotechnology company, has secured $50 million in Series B financing. The Column Group led the round.

Source: Press Release